- Home
- ZETA vs BPMC Comparison
ZETA vs BPMC Comparison
Compare ZETA & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZETA
- BPMC
- Stock Information
- Founded
- ZETA 2007
- BPMC 2008
- Country
- ZETA United States
- BPMC United States
- Employees
- ZETA N/A
- BPMC N/A
- Industry
- ZETA EDP Services
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- ZETA Technology
- BPMC Health Care
- Exchange
- ZETA Nasdaq
- BPMC Nasdaq
- Market Cap
- ZETA 5.0B
- BPMC 5.8B
- IPO Year
- ZETA 2021
- BPMC 2015
- Fundamental
- Price
- ZETA $13.25
- BPMC $99.18
- Analyst Decision
- ZETA Strong Buy
- BPMC Buy
- Analyst Count
- ZETA 14
- BPMC 21
- Target Price
- ZETA $29.23
- BPMC $124.05
- AVG Volume (30 Days)
- ZETA 4.3M
- BPMC 1.0M
- Earning Date
- ZETA 05-01-2025
- BPMC 05-01-2025
- Dividend Yield
- ZETA N/A
- BPMC N/A
- EPS Growth
- ZETA N/A
- BPMC N/A
- EPS
- ZETA N/A
- BPMC N/A
- Revenue
- ZETA $1,075,226,000.00
- BPMC $562,121,000.00
- Revenue This Year
- ZETA $25.28
- BPMC $44.85
- Revenue Next Year
- ZETA $18.49
- BPMC $32.06
- P/E Ratio
- ZETA N/A
- BPMC N/A
- Revenue Growth
- ZETA 40.36
- BPMC 99.19
- 52 Week Low
- ZETA $10.69
- BPMC $73.04
- 52 Week High
- ZETA $38.20
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- ZETA 52.80
- BPMC 65.95
- Support Level
- ZETA $12.89
- BPMC $97.91
- Resistance Level
- ZETA $14.50
- BPMC $104.86
- Average True Range (ATR)
- ZETA 0.59
- BPMC 3.74
- MACD
- ZETA 0.22
- BPMC 1.50
- Stochastic Oscillator
- ZETA 71.05
- BPMC 83.26
About ZETA Zeta Global Holdings Corp.
Zeta Global Holdings Corp is an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software. It serves enterprise customers across multiple industries, including financial services, insurance, telecommunications, automotive, travel and hospitality, and retail. Its Zeta Marketing Platform, or ZMP, is an omnichannel marketing platform with identity data at its core. The ZMP can analyze billions of structured and unstructured data points to predict consumer intent by leveraging sophisticated machine learning algorithms and the industry's opted-in data set for omnichannel marketing.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.